Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications
about
Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).AIF downregulation and its interaction with STK3 in renal cell carcinoma.Fluorescence in situ hybridization: molecular probes for diagnosis of pediatric neoplastic diseases.Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinomaChromogenic in situ hybridization analysis of HER-2/neu status in breast carcinoma: application in screening of patients for trastuzumab (Herceptin) therapy.Expression and functional characterization of LRRC4, a novel brain-specific member of the LRR superfamily.Primary peripheral PNET/Ewing's sarcoma of the dura: a clinicopathologic entity distinct from central PNET.Testing for HER2 in breast cancer.Undifferentiated small round cell sarcomas with rare EWS gene fusions: identification of a novel EWS-SP3 fusion and of additional cases with the EWS-ETV1 and EWS-FEV fusions.Delineation of HER2 gene status in breast carcinoma by silver in situ hybridization is reproducible among laboratories and pathologists.Interphase fluorescence in situ hybridization for detection of 8q24/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions.Ewing's sarcoma and peripheral primitive neuroectodermal tumor in adults: different features of a rare neoplasm.Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections.
P2860
Q30959521-0DC0297D-4402-47AA-B169-A79F2116B59BQ31029884-AF45AA0B-73E5-4782-BD14-128319114453Q33747747-FA39D286-354A-4CE7-A65A-BBF02E5020C3Q33843217-068D29F5-D3D4-4B08-99FD-2DE383649C35Q33855951-56C6E06E-C854-4306-AE42-B807F4B93750Q34064466-0CF1EE3F-F41D-4AD1-B455-12F090B59DB6Q34091814-D850A42D-9EF0-4973-9FB9-CA81C549C1DEQ34427781-800FD8A0-AEDA-496F-96DE-57C30640F9E6Q34686670-0C054ECA-11F4-457C-98AF-07E8DC5F00FCQ35871999-D7C4433D-EC42-48B1-8FAF-18C85D255CB0Q35988144-7716B96A-3031-4980-A6BD-0A60A66C1620Q36944264-9FFDBA99-C2A1-4112-B02E-44AD3B3FFE34Q38882292-24DC0257-13DC-4958-93F8-D55C83F453E9Q50459584-5A65E863-914C-494F-B7A6-7E3D767A03E7Q52032543-E7E2D4E9-6DAE-4DE9-A65A-CA9DDCF2AEF2
P2860
Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Subtracted, unique-sequence, i ...... al and diagnostic applications
@ast
Subtracted, unique-sequence, i ...... al and diagnostic applications
@en
type
label
Subtracted, unique-sequence, i ...... al and diagnostic applications
@ast
Subtracted, unique-sequence, i ...... al and diagnostic applications
@en
prefLabel
Subtracted, unique-sequence, i ...... al and diagnostic applications
@ast
Subtracted, unique-sequence, i ...... al and diagnostic applications
@en
P2093
P2860
P1476
Subtracted, unique-sequence, i ...... al and diagnostic applications
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65727-6
P407
P577
1998-11-01T00:00:00Z